Amplifier system and controls for dielectrophoretic tracking in microfluidic devices

US12297481B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12297481-B2
Application numberUS-202217750880-A
CountryUS
Kind codeB2
Filing dateMay 23, 2022
Priority dateOct 9, 2014
Publication dateMay 13, 2025
Grant dateMay 13, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems, methods, and devices are described herein for identifying, monitoring, isolating, or selecting a cell having a predefined characteristic in a mixed population of cells utilizing a combination of any one or more of iDEP, a region of localized field enhancement, a variable frequency electric field, a wide bandwidth amplifier, and/or an imaging apparatus.

First claim

Opening claim text (preview).

We claim: 1. A system comprising a paired and counter-phase amplifier unit coupled to electrodes in a dielectrophoresis microfluidic device, the system comprising: the dielectrophoresis microfluidic device comprising: an elongate channel having an inlet defining a first end, and an outlet defining a second end, and having at least one spatially localized high-field region configured to provide translation of a particle or cell in an insulator dielectrophoresis (iDEP) control operation; and the electrodes comprising a first electrode and a second electrode located in the dielectrophoresis microfluidic device to generate a spatially non-uniform electric field at the at least one spatially localized high-field region; the paired and counter-phase amplifier unit comprising: a wideband splitter unit adapted to generate counter-phase input signals comprising a first signal and a second signal from an input signal, wherein the second signal is 180° phase-shifted from the first signal; and wideband power amplifiers comprising a first amplifier and a second amplifier, wherein an input of the first amplifier is coupled to a first output of the wideband splitter unit to receive the first signal, and wherein an input of the second amplifier is coupled to a second output of the wideband splitter unit to receive the second signal, and wherein the first amplifier and second amplifier are configured to generate counter-phase output signals applied to the first and second electrodes by amplifying a voltage difference between the first signal and the second signal to an output voltage twice that of individual outputs of the first and second signals at a range between, and inclusive of, 20 V and 1000 V, and wherein the counter-phase output signals have a frequency between, and inclusive of, 0.01 MHz and 10 MHz; and an adjustable power supply operably connected with the paired and counter-phase amplifier unit and configured for feedback control for a constant power output for the insulator dielectrophoresis control operation. 2. The system of claim 1 , wherein each of the first and second electrodes is located outside the at least one spatially localized high-field region. 3. The system of claim 2 , wherein the system is configured for single particle tracking. 4. The system of claim 3 , wherein the system is configured for single particle dielectrophoretic translation of bio-particles under electric fields. 5. The system of claim 4 , wherein the paired and counter-phase amplifier unit is operably connected for electrical stimulation and measurements with the microfluidic device and the single particle trapping is performed in one or more insulator constriction regions in the dielectrophoresis microfluidic device. 6. The system of claim 1 , wherein the adjustable power supply is self-adjustable, via the feedback control, for dynamic modulation of supply voltages in response to measurements from the dielectrophoresis microfluidic device. 7. The system of claim 6 , wherein the paired and counter-phase amplifier unit is configured to deliver the constant power output for avoiding over-heating and signal distortion due to signal saturation. 8. The system of claim 7 , wherein the paired and counter-phase amplifier unit is configured to reduce dynamic distortions and parasitic voltage drops within the counter-phase output signals of the first and second amplifiers. 9. The system of claim 1 , wherein the at least one spatially localized high-field region comprises insulator constrictions or field non-uniformities. 10. The system of claim 9 , wherein the system is configured to position and measure cells within respective media in the at least one spatially localized high field region. 11. The system of claim 1 , wherein the first and second amplifiers are provided with the first and second signals each having a same amplitude. 12. The system of claim 1 , wherein the first and second amplifiers are each operational amplifiers (Op-amps). 13. The system of claim 1 , wherein the wideband splitter unit comprises super-fast low-power Op-amps. 14. The system of claim 1 , further comprising an attenuator and a controllable signal generator, wherein the controllable signal generator is connected to the first amplifier and the second amplifier to provide a source signal for the counter-phase output signals. 15. The system of claim 1 , wherein each of the first and second amplifier has a slew rate of over 2500 V/μs to provide the counter-phase output signals with a slew rate of over 5000 V/μs. 16. The system of claim 1 , wherein each of the first and second amplifier has a slew rate of over 3000 V/μs to provide the counter-phase output signals with a slew rate of over 6000 V/μs. 17. The system of claim 1 , wherein each of the first and second amplifier has a slew rate of over 4000 V/μs to provide the counter-phase output signals with a slew rate of over 8000 V/μs. 18. The system of claim 1 , wherein each of the first and second amplifier has a slew rate of 5000 V/μs to provide the counter-phase output signals with a slew rate of 10000 V/μs. 19. The system of claim 1 , wherein the paired and counter-phase amplifier unit is operably connected with the dielectrophoresis microfluidic device and is configured to output at a high voltage and a high frequency selected from the group consisting of: 300 V pp at 100 KHz, 300 V pp at 1 MHz, 300 V pp at 3 MHz, and 250 V pp at 5 MHz. 20. The system of claim 1 , wherein the first and second electrodes are configured to focus and concentrate particles in a flowing aqueous suspension.

Assignees

Inventors

Classifications

  • Dielectrophoresis, i.e. dielectric particles migrating towards the region of highest field strength · CPC title

  • Bacteria · CPC title

  • of liquid biological material · CPC title

  • for use in medical or biological applications · CPC title

  • B03C5/026Primary

    using open-gradient differential dielectric separation, i.e. using electrodes of special shapes for non-uniform field creation, e.g. Fluid Integrated Circuit [FIC] · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12297481B2 cover?
Systems, methods, and devices are described herein for identifying, monitoring, isolating, or selecting a cell having a predefined characteristic in a mixed population of cells utilizing a combination of any one or more of iDEP, a region of localized field enhancement, a variable frequency electric field, a wide bandwidth amplifier, and/or an imaging apparatus.
Who is the assignee on this patent?
Univ Virginia Patent Foundation
What technology area does this patent fall under?
Primary CPC classification B03C5/026. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).